Medication info
Donete Tablet 10 mg (Donepezil Hydrochloride Monohydrate)

Donete Tablet 10 mg (Donepezil Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Donepezil Hydrochloride Hydrate›10.43mg / 1 tablet
Manufacturer / importer
KMS Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201600794 · Approved 2016.02.11 · Insurance code 654701650

Summary

Main use
Treatment of symptoms of Alzheimer-type dementia
Who takes it
Adults · Children
Adult dose
○ Adults: Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, taking this medicine in the morning may be considered. Since donepezil concentrations reach steady state 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose increase, administer the 5 mg dose for 4~6 weeks. After assessing the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg per day, administer with caution for gastrointestinal adverse reactions. If this medicine is discontinued, its effects gradually diminish; no rebound effect occurs with abrupt discontinuation. ○ Female patients aged 85 years and older who are underweight: Careful monitoring is required because adverse reactions occur more frequently. Underweight elderly women should not exceed 5 mg per day.
Child dose
○ Children: There is no experience with use in children.

Ingredients

Manufacturer
KMS Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of symptoms of Alzheimer-type dementia

  • Symptoms of Alzheimer-type dementia
View approved original text

This medication is used to treat symptoms of Alzheimer-type dementia. It helps improve memory loss and cognitive function due to dementia, thereby enhancing the quality of daily life.

How to take

Adult dose

○ Adults: Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, taking this medicine in the morning may be considered. Since donepezil concentrations reach steady state 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose increase, administer the 5 mg dose for 4~6 weeks. After assessing the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg per day, administer with caution for gastrointestinal adverse reactions. If this medicine is discontinued, its effects gradually diminish; no rebound effect occurs with abrupt discontinuation. ○ Female patients aged 85 years and older who are underweight: Careful monitoring is required because adverse reactions occur more frequently. Underweight elderly women should not exceed 5 mg per day.

Child dose

○ Children: There is no experience with use in children.

Precautions

This medication contains Donepezil Hydrochloride and is used for the treatment of symptoms of Alzheimer-type dementia. First, this medication should not be used in individuals allergic to donepezil hydrochloride, piperidine derivatives, or any of its components. Pregnant women, women who are likely to become pregnant, and nursing mothers should also avoid taking this medication. Moreover, patients with genetic metabolic issues such as lactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take this medication. Patients with cardiovascular diseases or cardiac conduction disorders should use this medication with caution, as it may cause bradycardia or arrhythmias. Caution is also needed for patients who are taking non-steroidal anti-inflammatory drugs (NSAIDs) or have a history of peptic ulcers, as this may worsen symptoms due to increased gastric acid secretion. Patients with a history of asthma or obstructive pulmonary disease should use this medication cautiously, as it may lead to bronchoconstriction and increased mucus secretion. Patients with extrapyramidal disorders such as Parkinson's disease should also be cautious, as symptoms may worsen. Additionally, caution is required if allergic to Tartrazine, an ingredient in this medication. While taking this medication, various side effects may occur. For example, cardiac-related adverse reactions such as syncope, bradycardia, heart block, myocardial infarction, and heart failure have been reported, as well as peptic ulcers, gastrointestinal bleeding, liver dysfunction, intracerebral hemorrhage, seizures, extrapyramidal symptoms, neuroleptic malignant syndrome, rhabdomyolysis, dyspnea, acute pancreatitis, acute renal failure, and unexplained sudden death. Common side effects may include loss of appetite, nausea, vomiting, diarrhea, dizziness, insomnia, headache, fatigue, rash, and psychiatric symptoms such as hallucinations, agitation, aggressive behavior, anxiety, and confusion. This medication is approved only for patients with Alzheimer-type dementia and is not to be used for other forms of dementia or memory disorders. Treatment must be conducted under the supervision and diagnosis of an experienced physician, and if no therapeutic effects are observed, discontinuation should be considered. This medication may slow the heart rate and cause arrhythmias, so patients with cardiovascular disease or electrolyte abnormalities should use caution and be monitored with electrocardiograms if necessary. Additionally, since this medication increases gastric acid secretion and can accelerate gastrointestinal motility, patients with a history of peptic ulcers should monitor their condition closely. It may affect the ability to drive or operate machinery, especially at the start of treatment or when increasing the dosage. Pregnant or nursing women are advised not to take this medication, and if necessary, breastfeeding should be discontinued. The safety of this medication in children has not been established, thus it is not used in this population. There may be drug interactions, especially with medications that inhibit or induce CYP3A4 or CYP2D6, neuromuscular blockers, anticholinergic drugs, medications affecting cardiac conduction, and NSAIDs, so caution is warranted. In case of overdose, symptoms such as nausea, vomiting, sweating, bradycardia, hypotension, respiratory depression, and seizures may occur, and immediate medical attention is required. Atropine may be used as an antidote. This medication should be kept out of the reach of children and should not be transferred to another container.

Side effects

Syncope, bradycardia, heart block, QT interval prolongation, myocardial infarction, heart failure, peptic ulcer, perforation of the duodenum, gastrointestinal bleeding, hepatitis, liver dysfunction, jaundice, cerebellar seizures, cerebral hemorrhage, cerebrovascular disorders, motor dysfunction, ataxia, movement disorders, dystonia, tremors, involuntary movements, gait disturbances, abnormal posture, speech disorders, akinetic mutism, extreme muscle rigidity, dysphagia, tachycardia, blood pressure fluctuations, sweating, renal impairment accompanied by myoglobinuria, rhabdomyolysis, myalgia, weakness, increased CK in blood and urine, respiratory distress, acute pancreatitis, acute renal failure, unexplained sudden death, cold, anorexia, hallucinations, agitation, aggressive behavior, anxiety disorders, insomnia, drowsiness, increased libido, talkativeness, mania, nightmares, hyperesthesia, nonsense, delusions, depression, confusion, apathy, hyperactivity, hypersexuality, syncope, dizziness, insomnia, tremors, seizures, stupor, chest wall rigidity, bradycardia, palpitations, sinoatrial block, atrioventricular block, hypertension, hypotension, atrial fibrillation, torsades de pointes ventricular tachycardia, ECG QT interval prolongation, diarrhea, nausea, vomiting, abdominal disorders, gastrointestinal bleeding, gastric and duodenal ulcers, constipation, salivation, dysphagia, fecal incontinence, rash, pruritus, muscle spasms, myalgia, urinary incontinence, frequent urination, urinary retention, headache, fatigue, pain, toothache, facial flushing, malaise, asthenia, edema, fever, decreased body temperature, decreased hematocrit, leukopenia, anemia, thrombocytopenia, falls, accidents, decreased appetite, urinary tract infection, petechiae, abnormal dreams, eczema, urinary incontinence, increased CPK, dehydration, hyperlipidemia, insomnia, hostility, irritability, drowsiness, depression, confusion, emotional instability, personality disorders, eczema, urinary incontinence, abdominal pain, weakness, fungal infections, influenza-like illness, allergies, soft tissue infections, malaise, sepsis, facial edema, hernia, hypotension, bradycardia, abnormal ECG, heart failure, myocardial infarction, angina pectoris, atrial fibrillation, congestive heart failure, peripheral vascular disease, supraventricular ectopic beats, ventricular ectopic beats, cardiac hypertrophy, constipation, gastroenteritis, fecal incontinence, dyspepsia, increased γ-GT, gastritis, dysphagia, periodontitis, gastric ulcer, periodontal abscess, abdominal distension, liver dysfunction, belching, esophagitis, rectal bleeding, diabetes, anemia, leukocytosis, weight loss, peripheral edema, edema, increased LDH, increased alkaline phosphatase, hypercholesterolemia, hypokalemia, hypoglycemia, weight gain, hyperbilirubinemia, increased BUN, B12 deficiency anemia, cachexia, increased creatinine, gout, hyponatremia, hypoproteinemia, iron deficiency anemia, increased AST, increased ALT, arthritis, arthropathy, bone fractures, arthralgia, leg cramps, osteoporosis, myalgia, anxiety, agitation, tremors, spasms, transient psychosis, gait abnormalities, apathy, dizziness, delusions, abnormal dreams, cerebrovascular abnormalities, increased salivation, ataxia, abnormal euphoria, vasodilation, cerebral hemorrhage, cerebral infarction, cerebral ischemia, dementia, extrapyramidal symptoms, grand mal seizures, hemiplegia, hypertonia, reduced activity, pharyngitis, pneumonia, increased cough, bronchitis, respiratory distress, rhinitis, asthma, rash, skin ulcers, pruritus, psoriasis, skin discoloration, herpes zoster, dry skin, sweating, urticaria, vesicular rash, conjunctivitis, glaucoma, visual disturbances, ear pain, tearing abnormalities, urinary tract infection, cystitis, hematuria, diabetes, vaginitis, urination disorders, frequent urination, proteinuria, abdominal pain, anxiety, cholecystitis, confusion, spasms, hallucinations, heart block, hemolytic anemia, hepatitis, hyponatremia, neuroleptic malignant syndrome, pancreatitis, rash, nausea, vomiting, excessive salivation, sweating, hypotension, respiratory depression, debility, spasms, muscle weakness symptoms, death due to respiratory muscle relaxation, decreased voluntary behavior, supine position, staggering gait, tearing, clonic seizures, respiratory reduction, miosis, fibrous muscular spasms, decreased body surface temperature

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture exposure and kept at room temperature between 1 to 30 degrees Celsius. Therefore, it is advisable to avoid direct sunlight and do not place it in excessively hot or cold locations.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.